Story thread · 2 reports / 2 sources

Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train

endpts.com · 5h · first report

How the coverage leans

Across 2 sources · syndicated copies counted once

A California biotech with a chronic pain drug that's long been approved in Italy, but not the US, is going onto the public markets through the increasingly popular reverse merger route. Ambros ...

The coverage

  1. Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With Werewolf

    medcitynews.com · 1h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.